Ligand Pharmaceuticals Incorporated (LGND)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 20, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	2,166	1,245	1,128	2,581	1,599	1,832
Market Cap Growth	75.83%	10.35%	-56.28%	61.40%	-12.69%	-36.49%
Enterprise Value	1,954	1,061	1,121	2,589	1,264	1,325
Last Close Price	114.64	71.42	66.80	99.67	64.17	67.30
PE Ratio	46.38	23.88	-	45.18	-	2.91
Forward PE	57.32	35.07	-	-	33.23	11.25
PS Ratio	13.47	9.48	5.75	10.69	9.78	15.23
PB Ratio	2.56	1.78	1.89	3.14	2.25	2.39
P/TBV Ratio	3.97	5.40	8.11	7.85	-	4.15
P/FCF Ratio	28.84	27.04	9.41	36.86	31.90	-
P/OCF Ratio	28.26	25.12	8.19	32.76	29.30	-
PEG Ratio	3.82	2.34	-	-	1.61	0.48
EV/Sales Ratio	12.82	8.08	5.71	10.72	7.73	11.01
EV/EBITDA Ratio	37.13	23.34	20.60	22.09	18.31	34.85
EV/EBIT Ratio	108.69	108.04	369.11	39.07	30.77	-
EV/FCF Ratio	26.01	23.04	9.35	36.96	25.22	-
Debt / Equity Ratio	0.01	0.01	0.15	0.40	0.64	0.85
Debt / EBITDA Ratio	0.13	0.13	1.59	2.74	6.42	16.21
Debt / FCF Ratio	0.10	0.13	0.73	4.63	9.11	-
Asset Turnover	0.18	0.17	0.19	0.18	0.11	0.09
Inventory Turnover	1.54	1.88	4.38	3.50	4.20	9.33
Quick Ratio	10.83	12.49	2.50	10.39	4.70	65.38
Current Ratio	12.49	14.15	2.67	11.15	5.00	66.09
Return on Equity (ROE)	6.00%	8.29%	-0.74%	9.98%	0.89%	94.76%
Return on Assets (ROA)	1.30%	0.79%	0.18%	3.11%	1.80%	-0.26%
Return on Capital (ROIC)	1.48%	0.88%	0.21%	3.58%	1.99%	-0.27%
Earnings Yield	2.09%	4.19%	-2.96%	2.21%	-0.19%	34.36%
FCF Yield	3.47%	3.70%	10.63%	2.71%	3.13%	-1.74%
Buyback Yield / Dilution	-5.70%	-5.27%	2.19%	-2.50%	14.84%	17.91%
Total Shareholder Return	-5.70%	-5.27%	2.19%	-2.50%	14.84%	17.91%

Source: S&P Capital IQ. Standard template. Financial Sources.